Five Year Follow-Up Data Show Alemtuzumab Achieves Sustained Reduction In Relapses And Disability In Multiple Sclerosis
Links shared publicly online about this topic.
- 799total visits
Five Year Follow-Up Data Show Alemtuzumab Achieves Sustained Reduction In Relapses And Disability In Multiple Sclerosis
Patients with multiple sclerosis (MS) treated with alemtuzumab show sustained reduction in relapses and disability after five years, according to results reported at the European Committee for Tre
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Disability
Most Recently Shared on October 15, 2010 at 9:45 pm By:
Five Year Follow-Up Data Show Alemtuzumab Achieves Sustained Reduction In Relapses And Disability In Multiple Scle... http://mnt.to/f/3LgB
Also Shared By:
Advertisement
MNT Multiple Scl
@mnt_multiplescl
Five Year Follow-Up Data Show Alemtuzumab Achieves Sustained Reduction In Relapses And Disability In Multiple Sclerosis http://mnt.to/3LgB
1 year ago...